JAMA Dermatology: Highlights and Developments from 2025
-
By
-
Kanade Shinkai
-
May 1, 2026
Clinical Scorecard: JAMA Dermatology: Highlights and Developments from 2025
At a Glance
| Category | Detail |
|---|---|
| Condition | Dermatologic conditions |
| Key Mechanisms | Focus on evidence-based practices, AI integration, and timely publication |
| Target Population | Patients with skin diseases, including skin cancer and atopic dermatitis |
| Care Setting | Dermatology clinics and research institutions |
Key Highlights
- 3413 manuscripts evaluated with a 7% acceptance rate
- Median days from acceptance to publication reduced to 63 days
- High impact factor of 11 with over 11.2 million article views
- Notable studies on nicotinamide for skin cancer prevention and AI in dermatology
- Increased focus on climate change impacts on dermatologic health
Guideline-Based Recommendations
Diagnosis
- Utilize AI-guided risk stratification tools for skin cancer
- Consider total-body photography for high-risk melanoma detection
Management
- Recommend daily emollient use in infants to reduce atopic dermatitis incidence
- Evaluate the efficacy of novel treatments like next-generation bruton tyrosine kinase inhibitors
Monitoring & Follow-up
- Monitor the impact of AI-enabled devices on patient care and outcomes
Risks
- Assess potential overdiagnosis in melanoma screening practices
Patient & Prescribing Data
Individuals at risk for skin cancer and those with atopic dermatitis
Nicotinamide supplementation shows promise for secondary prevention of skin cancer
Clinical Best Practices
- Encourage rigorous evaluation of dermatologic studies to advance literature
- Promote collaboration with AI technologies to enhance patient care
- Incorporate qualitative studies to understand patient experiences in skin disease management
Related Resources & Content
Based on findings from:
JAMA Dermatology —The Year in Review, 2025
Kanade Shinkai. Jama Dermatology, 2026.
https://jamanetwork.com/journals/jamadermatology/fullarticle/2845993
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
